Loading data for PLSE — first visit, this takes a few seconds.
Pulse Biosciences, Inc. (PLSE)
NasdaqCM: PLSE
· 实时价格 · USD
53.11
-1.32 (-2.43%)
收盘价： Sep 11, 2026, 3:59 PM
52.11
-1.88%
盘后: 7:30 PM
股价、关键数字和最新消息，都在这一页。
Pulse Biosciences, Inc.（PLSE）股价、分析与数据
-2.43% (1D)
| 买价 | 39.73 |
| 市值 | 3.79B |
| 营收（TTM） | 1.19M |
| 净利润（TTM） | -80.1M |
| 1.62 | |
| -1.17 | |
| n/a | |
| -46.05 | |
| 市净率（TTM） | 37.80 |
| 市销率（TTM） | 3196.58 |
| 财报日期 | Nov 5, 2026 |
| 卖价 | 65.02 |
| 成交量 | 664,301 |
| 20日均量 | 454,922 |
| 开盘价 | 54.50 |
| 前收盘价 | 54.43 |
| 日内区间 | 50.31 - 56.61 |
| 52周区间 | 12.56 - 58.90 |
| 分析师 | n/a |
| 目标价 | n/a |
| 分红 | n/a |
| 除息日 | n/a |
关于 PLSE
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutaneous Electrode system for soft tissue ablation in surgical setting; nPulse Cardiac Surgical Clamp designed for use in surgical treatment of atrial fibrillation (AF); nPulse Cardiac Catheter System designed to provide a circumferent...
公司完整简介财报意外
Pulse Biosciences 已于 Aug 6, 2026 发布季度财报：
- 营收为 $434K 低于预期 $0, ， Infinity% 同比增长.
- 每股收益为 -0.28 低于预期 0.00, ， 0.00% 同比增长.
第 1 页，共 2 页